Collegium Announces $50 Million Accelerated Share Repurchase Program
<p>STOUGHTON, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has entered into an Accelerated Share Repurchase (“ASR”) agreement with Jefferies LLC to repurchase $50 million of the Company’s common […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/collegium-announces-50-million-accelerated-share-repurchase-program/">Collegium Announces $50 Million Accelerated Share Repurchase Program</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>
Leave a Comment